Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, MA; Division of Otolaryngology, Beth Israel Deaconess Medical Center, Boston, MA; Department of Otology and Laryngology, Harvard Medical School, Boston, MA.
Int Forum Allergy Rhinol. 2013 Sep;3(9):755-61. doi: 10.1002/alr.21163. Epub 2013 Mar 15.
BACKGROUND: Allergic rhinitis (AR) and chronic rhinosinusitis (CRS) are a major burden to the healthcare system. Although no causal relationship has been established, previous work has demonstrated a strong association of AR with CRS. In this study, we sought to identify risk factors that may influence speed of development of CRS in patients with AR. METHODS: Retrospective review of all patients diagnosed with AR without CRS presenting to an otolaryngology clinic at a tertiary medical center as part of a multidisciplinary allergy evaluation between March 2004 and November 2011. Medical records were evaluated for clinicodemographic factors including age, gender, smoking history, medical comorbidities, categories of AR based on formal allergy testing, the presence of sinonasal anatomic variants on computed tomography as well as subsequent development of CRS. RESULTS: Faster progression to CRS in patients with AR was associated with comorbid asthma (hazard ratio [HR] = 3.97) as well as sinonasal anatomic variants, such as infraorbital cells (HR = 7.39), and frontal intersinus cells (HR = 68.03), on multivariate survival analysis. A statistically significant but negative interaction between infraorbital cells and frontal intersinus cells suggests that concomitant presence of both leads to a less than additive increase in the rate of CRS progression. CONCLUSION: Sinonasal anatomical variants, infraorbital cells, and frontal intersinus cells, as well as comorbid asthma are associated with faster development of CRS in patients with AR. The presence of these clinical risk factors identifies patients who should be counseled on compliance with medical therapy for AR.
背景:变应性鼻炎(AR)和慢性鼻-鼻窦炎(CRS)给医疗系统带来了巨大负担。虽然尚未确定因果关系,但先前的研究表明 AR 与 CRS 之间存在很强的关联性。在这项研究中,我们试图确定可能影响 AR 患者 CRS 发展速度的风险因素。
方法:回顾性分析 2004 年 3 月至 2011 年 11 月期间在一家三级医疗中心的耳鼻喉科诊所就诊的所有未患 CRS 的 AR 患者的病历,这些患者是作为多学科过敏评估的一部分进行诊断的。评估的临床资料包括年龄、性别、吸烟史、合并症、基于正式过敏测试的 AR 分类、计算机断层扫描(CT)上的鼻-鼻窦解剖变异以及随后 CRS 的发展情况。
结果:在 AR 患者中,以下因素与更快进展为 CRS 相关:合并哮喘(风险比 [HR] = 3.97)、鼻-鼻窦解剖变异,如眶下细胞(HR = 7.39)和额窦间细胞(HR = 68.03)。眶下细胞和额窦间细胞的多变量生存分析存在统计学显著但负性交互作用,表明两者同时存在导致 CRS 进展率的增加小于加性。
结论:鼻-鼻窦解剖变异、眶下细胞和额窦间细胞以及合并哮喘与 AR 患者更快发展为 CRS 相关。这些临床危险因素的存在可识别出需要接受 AR 医疗治疗依从性咨询的患者。
Int Forum Allergy Rhinol. 2013-3-15
Int Forum Allergy Rhinol. 2012-5-30
Am J Rhinol Allergy. 2010
Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2006-10
Am J Rhinol Allergy. 2016
J Fam Pract. 2012-2
Int J Pediatr Otorhinolaryngol. 2014-2
Am J Otolaryngol. 2024
Int Arch Otorhinolaryngol. 2022-8-1
Int Forum Allergy Rhinol. 2017-3
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2015-12-22
J Allergy Clin Immunol Pract. 2016
Allergy Rhinol (Providence). 2014-1
Int J Pediatr Otorhinolaryngol. 2014-2